Enveric Biosciences Q2 EPS $(0.76) Up From $(11.64) YoY

Benzinga Newsdesk www.benzinga.com Negative 63.5%

Neg 63.5% Neu 0% Pos 0%

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.76) per share. This is a 93.47 percent increase over losses of $(11.64) per share from the same period last year.